TY  - GEN
AU  - Goodkin,D E
AU  - Kanoti,G A
TI  - Ethical considerations raised by the approval of interferon beta-1b for the treatment of multiple sclerosis
SN  - 0028-3878
PY  - 1994///0222
KW  - Bioethics
KW  - Disclosure
KW  - Drug Approval
KW  - Ethical Analysis
KW  - Federal Government
KW  - Government Regulation
KW  - Guidelines as Topic
KW  - Humans
KW  - Interferon-beta
KW  - therapeutic use
KW  - Multicenter Studies as Topic
KW  - Multiple Sclerosis
KW  - drug therapy
KW  - Randomized Controlled Trials as Topic
KW  - Research Subjects
KW  - Risk Assessment
KW  - Therapeutic Human Experimentation
KW  - United States
KW  - Withholding Treatment
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1212/wnl.44.1.166
ER  -